-

12:45:14 AM

INVO Stock News

INVO - INVO Bioscience Inc

05/15/23 4:05 PM

Nasdaq : INVO

earningslow float

INVO Reports First Quarter 2023 Financial Results

Revenue was $348,025, an increase of 114% compared to $162,598, and up 25% sequentially compared to Q4 2022. Clinic revenue increased 181% to $297,381, compared to $105,848, and up 35% sequentially compared to Q4 2022. All reported clinic revenue is derived from the Company's INVO Center in Atlanta, Georgia, which is consolidated in the Company's financial...

RHEA-AI

neutral

05/08/23 4:15 PM

Nasdaq : INVO

conferencesearningslow float

INVO Bioscience to Report First Quarter 2023 Financial Results on Monday, May 15, 2023

INVO Bioscience, Inc., a commercial-stage fertility company focused on expanding access to advanced infertility treatment worldwide with its INVOcell ® medical device and the intravaginal culture procedure it enables,...

RHEA-AI

neutral

04/17/23 4:05 PM

Nasdaq : INVO

earningslow float

INVO Reports Fourth Quarter and Full Year 2022 Financial Results

INVO Bioscience, Inc., a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its INVOcell ® medical device and the intravaginal culture procedure it enables, today announced financial results for the fourth quarter and fiscal year ended December 31, 2022 and provided a business update.

RHEA-AI

neutral

04/11/23 5:30 PM

Nasdaq : INVO

conferencesearningslow float

INVO Bioscience to Report Fourth Quarter and Fiscal Year 2022 Financial Results on Monday, April 17, 2023

INVO Bioscience, Inc., a commercial-stage fertility company focused on expanding access to advanced infertility treatment worldwide with its INVOcell ® medical device and the intravaginal culture procedure it enables, will report financial results for its fourth quarter and fiscal year 2022, for the period ended December 31, 2022, after the market...

RHEA-AI

neutral

04/05/23 9:00 AM

Nasdaq : INVO

low float

INVO Congratulates Wisconsin Fertility Institute on Being Named One of America's Best Fertility Clinics by Newsweek

INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced

RHEA-AI

neutral

03/30/23 5:25 PM

Nasdaq : INVO

earningslow float

INVO Provides Preliminary Update on FY2022 Financial Results

INVO Bioscience, Inc., a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its INVOcell ® medical device and the intravaginal culture procedure it enables, today announced preliminary financial results for the fourth quarter and year ended December 31, 2022. For the year ended December 31, 2022,...

RHEA-AI

neutral

03/27/23 5:06 PM

Nasdaq : INVO

offeringlow float

INVO Bioscience Announces Closing of $3.0 Million Registered Direct Offering

INVO Bioscience, Inc., a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its INVOcell ® medical device and the intravaginal culture procedure it enables, today announced the closing of its previously announced registered direct offering of 3,680,000 shares of common stock, priced at-the-market...

RHEA-AI

neutral

03/24/23 8:00 AM

Nasdaq : INVO

offeringlow float

INVO Bioscience Announces Pricing of $3.0 Million Registered Direct Offering Priced At-The-Market

INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its INVOcell ® medical device and the intravaginal culture ("IVC") procedure it

RHEA-AI

neutral

03/20/23 9:00 AM

Nasdaq : INVO

acquisitionlow float

INVO Signs Binding Agreements to Acquire Wisconsin Fertility Institute

Accretive acquisition expected to add significant scale to INVO's operationsContributes over $5 million in incremental annual revenue as well as positive net incomeInitial transaction that establishes acquisitions as 3 rd key aspect of INVO's commercial strategy, in addition to building new INVO

RHEA-AI

positive

01/05/23 9:00 AM

Nasdaq : INVO

low float

INVO Bioscience Enters Distribution Agreement for Taiwan

INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its INVOcell® medical device and the intravaginal culture ("IVC") procedure it enables,

RHEA-AI

positive

1 2 3 4 5 6 7 8 Next